Portfolio (Quarterly)
Guide ↗
China Universal Asset Management Co., Ltd.
· CIK 0001906594| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 181 | VNDA | VANDA PHARMACEUTICALS INC | Healthcare | 9,630.0 | $85K | 0.01% | -727.0 | -7.0% | $8.82 | -29.9% |
| 182 | PRTA | PROTHENA CORP PLC | Healthcare | 8,772.0 | $84K | 0.01% | -664.0 | -7.0% | $9.55 | -2.1% |
| 183 | — | ZEVRA THERAPEUTICS INC | — | 9,174.0 | $82K | 0.01% | -666.0 | -6.8% | $8.96 | — |
| 184 | LENZ | LENZ THERAPEUTICS INC | Healthcare | 5,099.0 | $82K | 0.01% | -3K | -36.2% | $16.00 | -53.0% |
| 185 | BLTE | BELITE BIO INC - ADR | Healthcare | 500.0 | $80K | 0.01% | -4K | -90.0% | $159.96 | -9.8% |
| 186 | GLPG | GALAPAGOS NV-SPON ADR | Healthcare | 2,356.0 | $77K | 0.01% | -155.0 | -6.2% | $32.70 | -15.1% |
| 187 | MRVI | MARAVAI LIFESCIENCES HLDGS-A | Healthcare | 23,631.0 | $77K | 0.01% | -2K | -6.8% | $3.25 | +37.8% |
| 188 | ENTA | ENANTA PHARMACEUTICALS INC | Healthcare | 4,703.0 | $74K | 0.01% | -4K | -46.2% | $15.77 | -12.3% |
| 189 | XBI | SS SPDR S&P BIOTECH ETF | — | 608.0 | $74K | 0.01% | -4K | -87.6% | $121.93 | +8.9% |
| 190 | — | SOLID BIOSCIENCES INC | — | 12,695.0 | $72K | 0.01% | -954.0 | -7.0% | $5.64 | — |
| 191 | SIGA | SIGA TECHNOLOGIES INC | Healthcare | 11,669.0 | $71K | 0.01% | -882.0 | -7.0% | $6.11 | -26.5% |
| 192 | EOLS | EVOLUS INC | Healthcare | 10,562.0 | $70K | 0.01% | -776.0 | -6.8% | $6.65 | -3.0% |
| 193 | KYTX | KYVERNA THERAPEUTICS INC | Healthcare | 7,137.0 | $67K | 0.01% | -443.0 | -5.8% | $9.40 | -5.3% |
| 194 | AUTL | AUTOLUS THERAPEUTICS PLC | Healthcare | 32,687.0 | $65K | 0.01% | -2K | -7.0% | $1.99 | -17.1% |
| 195 | TRDA | ENTRADA THERAPEUTICS INC | Healthcare | 6,228.0 | $64K | 0.01% | -439.0 | -6.6% | $10.28 | -41.2% |
| 196 | RCKT | ROCKET PHARMACEUTICALS INC | Healthcare | 17,635.0 | $62K | 0.01% | -1K | -6.8% | $3.51 | -15.4% |
| 197 | AURA | AURA BIOSCIENCES INC | Healthcare | 10,348.0 | $56K | 0.00% | -541.0 | -5.0% | $5.45 | +40.4% |
| 198 | BCYC | BICYCLE THERAPEUTICS PLC-ADR | Healthcare | 7,540.0 | $53K | 0.00% | -564.0 | -7.0% | $7.08 | -37.1% |
| 199 | LRMR | LARIMAR THERAPEUTICS INC | Healthcare | 13,947.0 | $53K | 0.00% | -1K | -7.0% | $3.81 | -6.3% |
| 200 | AVXL | ANAVEX LIFE SCIENCES CORP | Healthcare | 14,559.0 | $52K | 0.00% | -497.0 | -3.3% | $3.56 | -23.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
39.5%
Healthcare
21.2%
Communication Services
12.4%
Financial Services
10.6%
Consumer Cyclical
10.1%
Consumer Defensive
2.7%
Industrials
1.9%
Utilities
0.6%
Basic Materials
0.5%
Energy
0.4%